Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

BUY
$237.11 - $299.66 $298,758 - $377,571
1,260 New
1,260 $319,000
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $257,269 - $315,760
-1,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $292,080 - $329,010
1,000 New
1,000 $329,000
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $244,988 - $299,187
-900 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$225.08 - $271.69 $202,572 - $244,521
900 New
900 $242,000
Q1 2021

May 12, 2021

SELL
$212.38 - $245.9 $318,570 - $368,850
-1,500 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $318,750 - $368,190
1,500 New
1,500 $333,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $151B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Enlightenment Research, LLC Portfolio

Follow Enlightenment Research, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Enlightenment Research, LLC with notifications on news.